KCPG
CBST

Kavar Capital Partners Group’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Kavar Capital Partners Group’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-12
Closed – – 548
2014
Q1 		$0 Hold
12
– – ﹤0.01% 606
2013
Q4 		$0 Buy
+12
New +$777 ﹤0.01% 534

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Kavar Capital Partners Group's CBST Position: Q2 2014 in Review

Kavar Capital Partners Group sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 12 shares.

Kavar Capital Partners Group first reported a position in CBST in Q4 2013 and held it in 2 quarters. The position peaked at $0 in Q1 2014. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Kavar Capital Partners Group reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Kavar Capital Partners Group sold 12 CUBIST PHARMACEUTICALS INC shares in Q2 2014.
  • Kavar Capital Partners Group first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Kavar Capital Partners Group's CUBIST PHARMACEUTICALS INC position peaked at $0 in Q1 2014.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Kavar Capital Partners Group's 13F filing for Q2 2014, filed 25 Jan 2019.